, Tracking Stock Market Picks
Enter Symbol:
Momenta Pharmaceuticals, Inc. (MNTA) [hlAlert]

down 33.33 %

Momenta Pharmaceuticals, Inc. (MNTA) rated Underperform by BofA/Merrill

Posted on: Tuesday,  Mar 19, 2013  8:25 AM ET by BofA/Merrill

BofA/Merrill rated Underperform Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) on 03/19/2013, when the stock price was $13.48. Since
then, Momenta Pharmaceuticals, Inc. has gained 50.00% as of 01/25/2016's recent price of $20.22.
If you would have followed this BofA/Merrill's recommendation on MNTA, you would have lost 33.33% of your investment in 1042 days.

Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the detailed structural analysis and design of complex sugars for the development of improved versions of existing drugs, the development of novel drugs and the discovery of new biological processes. Momenta is also utilizing its ability to sequence sugars to create technology-enabled generic products.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/19/2013 8:25 AM Sell
as of 12/13/2013
1 Week up  1.54 %
1 Month down  -2.49 %
3 Months down  -10.93 %
1 YTD down  -27.96 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy